{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:09:33Z","timestamp":1792807773994,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-022-08714-6","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:02:58Z","timestamp":1649203378000},"page":"6514-6525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A review on the added value of whole-body MRI in metastatic lobular breast cancer"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-1846","authenticated-orcid":false,"given":"Basrull N.","family":"Bhaludin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tunariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Messiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia F.","family":"Okines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair E.","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina M.","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romney","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R. D.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"8714_CR1","first-page":"632","volume":"114","author":"MJ Borst","year":"1993","unstructured":"Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114:632\u2013637","journal-title":"Surgery"},{"key":"8714_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1097-0142(197507)36:1<1::aid-cncr2820360102>3.0.co;2-4","volume":"36","author":"ER Fisher","year":"1975","unstructured":"Fisher ER, Gregorio RM, Fisher B et al (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 36:1\u201385. https:\/\/doi.org\/10.1002\/1097-0142(197507)36:1<1::aid-cncr2820360102>3.0.co;2-4","journal-title":"Cancer"},{"key":"8714_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2559.2007.02891.x","volume":"52","author":"AM Hanby","year":"2008","unstructured":"Hanby AM, Hughes TA (2008) In situ and invasive lobular neoplasia of the breast. Histopathology 52:58\u201366. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02891.x","journal-title":"Histopathology"},{"key":"8714_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/bjc.1984.135","volume":"50","author":"M Harris","year":"1984","unstructured":"Harris M, Howell A, Chrissohou M et al (1984) A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 50:23\u201330. https:\/\/doi.org\/10.1038\/bjc.1984.135","journal-title":"Br J Cancer"},{"key":"8714_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jso.2930480106","volume":"48","author":"J Lamovec","year":"1991","unstructured":"Lamovec J, Bra\u010dkko M (1991) Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol 48:28\u201333. https:\/\/doi.org\/10.1002\/jso.2930480106","journal-title":"J Surg Oncol"},{"key":"8714_CR6","doi-asserted-by":"publisher","unstructured":"Winston CB, Hadar O, Teitcher JB et al (2000) Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. AJR Am J Roentgenol 175:795\u2013800. https:\/\/doi.org\/10.2214\/ajr.175.3.1750795","DOI":"10.2214\/ajr.175.3.1750795"},{"key":"8714_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejca.2003.08.007","volume":"40","author":"S Ferlicot","year":"2004","unstructured":"Ferlicot S, Vincent-Salomon A, M\u00e9dioni J et al (2004) Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer 40:336\u2013341. https:\/\/doi.org\/10.1016\/j.ejca.2003.08.007","journal-title":"Eur J Cancer"},{"key":"8714_CR8","doi-asserted-by":"publisher","first-page":"e0182397","DOI":"10.1371\/journal.pone.0182397","volume":"12","author":"Z Chen","year":"2017","unstructured":"Chen Z, Yang J, Li S et al (2017) Invasive lobular carcinoma of the breast: a special histological type compared with invasive ductal carcinoma. PLoS One 12:e0182397. https:\/\/doi.org\/10.1371\/journal.pone.0182397","journal-title":"PLoS One"},{"key":"8714_CR9","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.21873\/anticanres.15275","volume":"41","author":"J Watanabe","year":"2021","unstructured":"Watanabe J, Nakamoto S, Sugino T (2021) The real-world outcomes of patients with advanced invasive lobular carcinoma of the breast compared with invasive ductal carcinoma: a review at a single institution. Anticancer Res 41:4619. https:\/\/doi.org\/10.21873\/anticanres.15275","journal-title":"Anticancer Res"},{"key":"8714_CR10","unstructured":"The Royal College of Radiologists (2019) Guidance on screening and symptomatic breast imaging, Fourth edn Clinical Radiology The Royal College of Radiologists"},{"key":"8714_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/1754-9485.13038","volume":"64","author":"A Miles","year":"2020","unstructured":"Miles A, Evans RE, Halligan S et al (2020) Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT\/ PET-CT for staging colorectal or lung cancer. J Med Imaging Radiat Oncol 64:537\u2013545. https:\/\/doi.org\/10.1111\/1754-9485.13038","journal-title":"J Med Imaging Radiat Oncol"},{"key":"8714_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/leu.2015.338","volume":"30","author":"C Pawlyn","year":"2016","unstructured":"Pawlyn C, Fowkes L, Otero S et al (2016) Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma? Leukemia 30:1446\u20131448. https:\/\/doi.org\/10.1038\/leu.2015.338","journal-title":"Leukemia"},{"key":"8714_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clinimag.2018.08.004","volume":"52","author":"S Oliveri","year":"2018","unstructured":"Oliveri S, Paola P, Silvia P et al (2018) Investigating cancer patient acceptance of whole body MRI. Clin Imaging 52:246\u2013251. https:\/\/doi.org\/10.1016\/j.clinimag.2018.08.004","journal-title":"Clin Imaging"},{"key":"8714_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14827","volume":"178","author":"A Chantry","year":"2017","unstructured":"Chantry A, Kazmi M, Barrington S et al (2017) Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol 178:380\u2013393. https:\/\/doi.org\/10.1111\/bjh.14827","journal-title":"Br J Haematol"},{"key":"8714_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S et al (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology 291:5\u201313. https:\/\/doi.org\/10.1148\/radiol.2019181949","journal-title":"Radiology"},{"key":"8714_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","volume":"71","author":"AR Padhani","year":"2017","unstructured":"Padhani AR, Lecouvet FE, Tunariu N et al (2017) Metastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71:81\u201392. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.033","journal-title":"Eur Urol"},{"key":"8714_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41416-020-01175-y","volume":"124","author":"C Bailleux","year":"2021","unstructured":"Bailleux C, Eberst L, Bachelot T (2021) Treatment strategies for breast cancer brain metastases. Br J Cancer 124:142\u2013155. https:\/\/doi.org\/10.1038\/s41416-020-01175-y","journal-title":"Br J Cancer"},{"key":"8714_CR18","doi-asserted-by":"publisher","unstructured":"Ji L, Cheng L, Zhu X, Gao Y, Fan L, Wang Z (2021) Risk and prognostic factors of breast cancer with liver metastases. BMC Cancer 21:238. https:\/\/doi.org\/10.1186\/s12885-021-07968-5","DOI":"10.1186\/s12885-021-07968-5"},{"key":"8714_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.mric.2010.10.004","volume":"19","author":"AR Padhani","year":"2011","unstructured":"Padhani AR, Koh DM (2011) Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am 19:181\u2013209. https:\/\/doi.org\/10.1016\/j.mric.2010.10.004","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"8714_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1148\/radiology.189.3.7694312","volume":"189","author":"BD Fletcher","year":"1993","unstructured":"Fletcher BD, Wall JE, Hanna SL (1993) Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy. Radiology 189:745\u2013751. https:\/\/doi.org\/10.1148\/radiology.189.3.7694312","journal-title":"Radiology"},{"key":"8714_CR21","doi-asserted-by":"publisher","unstructured":"Padhani AR, Makris A, Gall P, Collins DJ, Tunariu N, deBono JS (2014) Therapy monitoring of skeletal metastases with whole-body diffusion MRI. J Magn Reson Imaging 39:1049\u20131078. https:\/\/doi.org\/10.1002\/jmri.24548","DOI":"10.1002\/jmri.24548"},{"key":"8714_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1148\/radiol.2483071407","volume":"248","author":"Y Cui","year":"2008","unstructured":"Cui Y, Zhang X-P, Sun Y-S et al (2008) Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 248:894\u2013900. https:\/\/doi.org\/10.1148\/radiol.2483071407","journal-title":"Radiology"},{"key":"8714_CR23","doi-asserted-by":"publisher","unstructured":"Theilmann RJ, Borders R, Trouard TP et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831\u2013837. https:\/\/doi.org\/10.1593\/neo.03343","DOI":"10.1593\/neo.03343"},{"key":"8714_CR24","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.2147\/CMAR.S167924","volume":"10","author":"MV Godinho","year":"2018","unstructured":"Godinho MV, Lopes FPPL, Costa FM (2018) Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer. Cancer Manag Res 10:6743\u20136756. https:\/\/doi.org\/10.2147\/CMAR.S167924","journal-title":"Cancer Manag Res"},{"key":"8714_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/annonc\/mdu558","volume":"26","author":"DK Woolf","year":"2015","unstructured":"Woolf DK, Padhani AR, Makris A (2015) Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? Ann Oncol 26:1048\u20131057. https:\/\/doi.org\/10.1093\/annonc\/mdu558","journal-title":"Ann Oncol"},{"key":"8714_CR26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","volume":"24","author":"K Michielsen","year":"2014","unstructured":"Michielsen K, Vergote I, Op De Beeck K et al (2014) Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT. Eur Radiol 24:889\u2013901. https:\/\/doi.org\/10.1007\/s00330-013-3083-8","journal-title":"Eur Radiol"},{"key":"8714_CR27","doi-asserted-by":"publisher","unstructured":"van \u2019t Sant I, Engbersen MP, Bhairosing PA, et al (2020) Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol 30:3101\u20133112. https:\/\/doi.org\/10.1007\/s00330-019-06524-x","DOI":"10.1007\/s00330-019-06524-x"},{"key":"8714_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0205251","volume":"13","author":"F Zugni","year":"2018","unstructured":"Zugni F, Ruju F, Pricolo P et al (2018) The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer. PLoS One 13:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0205251","journal-title":"PLoS One"},{"key":"8714_CR29","doi-asserted-by":"publisher","unstructured":"DiPiro PJ, Tirumani SH, Cruz GP et al (2019) Lobular breast cancer: patterns of intraabdominal metastatic spread on imaging and prognostic significance. Abdom Radiol (NY) 44:362\u2013369. https:\/\/doi.org\/10.1007\/s00261-018-1722-x","DOI":"10.1007\/s00261-018-1722-x"},{"key":"8714_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1148\/rg.305105073","volume":"30","author":"S Kyriazi","year":"2010","unstructured":"Kyriazi S, Collins DJ, Morgan VA et al (2010) Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 30:1269\u20131285. https:\/\/doi.org\/10.1148\/rg.305105073","journal-title":"Radiographics"},{"key":"8714_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1148\/radiology.219.1.r01ap28213","volume":"219","author":"DL Brown","year":"2001","unstructured":"Brown DL, Zou KH, Tempany CM et al (2001) Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology 219:213\u2013218. https:\/\/doi.org\/10.1148\/radiology.219.1.r01ap28213","journal-title":"Radiology"},{"key":"8714_CR32","doi-asserted-by":"publisher","unstructured":"He H, Gonzalez A, Robinson E, Yang WT (2014) Distant metastatic disease manifestations in infiltrating lobular carcinoma of the breast. AJR Am J Roentgenol 202:1140\u20131148. https:\/\/doi.org\/10.2214\/AJR.13.11156","DOI":"10.2214\/AJR.13.11156"},{"key":"8714_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ejca.2006.01.026","volume":"42","author":"P Therasse","year":"2006","unstructured":"Therasse P, Eisenhauer EA, Verweij J (2006) RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 42:1031\u20131039. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.026","journal-title":"Eur J Cancer"},{"key":"8714_CR34","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","volume":"21","author":"HL Yang","year":"2011","unstructured":"Yang HL, Liu T, Wang XM et al (2011) Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. Eur Radiol 21:2604\u20132617. https:\/\/doi.org\/10.1007\/s00330-011-2221-4","journal-title":"Eur Radiol"},{"key":"8714_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"8714_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12149-017-1202-3","volume":"31","author":"T Sugihara","year":"2017","unstructured":"Sugihara T, Koizumi M, Koyama M et al (2017) Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors. Ann Nucl Med 31:719\u2013725. https:\/\/doi.org\/10.1007\/s12149-017-1202-3","journal-title":"Ann Nucl Med"},{"key":"8714_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.bjc.6605546","volume":"102","author":"T Hamaoka","year":"2010","unstructured":"Hamaoka T, Costelloe CM, Madewell JE et al (2010) Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. Br J Cancer 102:651\u2013657. https:\/\/doi.org\/10.1038\/sj.bjc.6605546","journal-title":"Br J Cancer"},{"key":"8714_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2967\/jnumed.119.234260","volume":"61","author":"GJR Cook","year":"2020","unstructured":"Cook GJR, Goh V (2020) Molecular Imaging of Bone Metastases and Their Response to Therapy. J Nucl Med 61:799\u2013806. https:\/\/doi.org\/10.2967\/jnumed.119.234260","journal-title":"J Nucl Med"},{"key":"8714_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00259-013-2532-6","volume":"41","author":"H Palmedo","year":"2014","unstructured":"Palmedo H, Marx C, Ebert A et al (2014) Whole-body SPECT\/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging 41:59\u201367. https:\/\/doi.org\/10.1007\/s00259-013-2532-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8714_CR40","unstructured":"Savelli G, Maffioli L, Maccauro M, et al (2001) Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 45:27\u201337"},{"key":"8714_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1200\/JCO.1995.13.5.1123","volume":"13","author":"CL Vogel","year":"1995","unstructured":"Vogel CL, Schoenfelder J, Shemano I et al (1995) Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer. J Clin Oncol 13:1123\u20131128. https:\/\/doi.org\/10.1200\/JCO.1995.13.5.1123","journal-title":"J Clin Oncol"},{"key":"8714_CR42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.suronc.2013.01.002","volume":"22","author":"J Rong","year":"2013","unstructured":"Rong J, Wang S, Ding Q et al (2013) Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis. Surg Oncol 22:86\u201391. https:\/\/doi.org\/10.1016\/j.suronc.2013.01.002","journal-title":"Surg Oncol"},{"key":"8714_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/RLU.0b013e31815f23b7","volume":"33","author":"P Shie","year":"2008","unstructured":"Shie P, Cardarelli R, Brandon D et al (2008) Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer. Clin Nucl Med 33:97\u2013101. https:\/\/doi.org\/10.1097\/RLU.0b013e31815f23b7","journal-title":"Clin Nucl Med"},{"key":"8714_CR44","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1007\/s00259-015-3080-z","volume":"42","author":"BZ Dashevsky","year":"2015","unstructured":"Dashevsky BZ, Goldman DA, Parsons M et al (2015) Appearance of untreated bone metastases from breast cancer on FDG PET\/CT: importance of histologic subtype. Eur J Nucl Med Mol Imaging 42:1666\u20131673. https:\/\/doi.org\/10.1007\/s00259-015-3080-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8714_CR45","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","volume":"18","author":"N Avril","year":"2000","unstructured":"Avril N, Ros\u00e9 CA, Schelling M et al (2000) Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: Use and limitations. J Clin Oncol 18:3495\u20133502. https:\/\/doi.org\/10.1200\/JCO.2000.18.20.3495","journal-title":"J Clin Oncol"},{"key":"8714_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1200\/JCO.2002.20.2.379","volume":"20","author":"R Bos","year":"2002","unstructured":"Bos R, van Der Hoeven JJM, van Der Wall E et al (2002) Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 20:379\u2013387. https:\/\/doi.org\/10.1200\/JCO.2002.20.2.379","journal-title":"J Clin Oncol"},{"key":"8714_CR47","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00330-006-0361-8","volume":"17","author":"GP Schmidt","year":"2007","unstructured":"Schmidt GP, Schoenberg SO, Schmid R et al (2007) Screening for bone metastases: Whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 17:939\u2013949. https:\/\/doi.org\/10.1007\/s00330-006-0361-8","journal-title":"Eur Radiol"},{"key":"8714_CR48","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1148\/radiol.2020192683","volume":"297","author":"M Kosmin","year":"2020","unstructured":"Kosmin M, Padhani AR, Gogbashian A et al (2020) Comparison of whole-body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone. Radiology 297:622\u2013629. https:\/\/doi.org\/10.1148\/radiol.2020192683","journal-title":"Radiology"},{"key":"8714_CR49","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00330-018-5720-8","volume":"29","author":"D Botsikas","year":"2019","unstructured":"Botsikas D, Bagetakos I, Picarra M et al (2019) What is the diagnostic performance of 18-FDG-PET\/MR compared to PET\/CT for the N- and M- staging of breast cancer? Eur Radiol 29:1787\u20131798. https:\/\/doi.org\/10.1007\/s00330-018-5720-8","journal-title":"Eur Radiol"},{"key":"8714_CR50","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1007\/s00259-020-04801-2","volume":"47","author":"NM Bruckmann","year":"2020","unstructured":"Bruckmann NM, Sawicki LM, Kirchner J et al (2020) Prospective evaluation of whole-body MRI and (18)F-FDG PET\/MRI in N and M staging of primary breast cancer patients. Eur J Nucl Med Mol Imaging 47:2816\u20132825. https:\/\/doi.org\/10.1007\/s00259-020-04801-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8714_CR51","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.1007\/s00330-021-07956-0","volume":"31","author":"NM Bruckmann","year":"2021","unstructured":"Bruckmann NM, Kirchner J, Umutlu L et al (2021) Prospective comparison of the diagnostic accuracy of 18F-FDG PET\/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. Eur Radiol 31:8714\u20138724. https:\/\/doi.org\/10.1007\/s00330-021-07956-0","journal-title":"Eur Radiol"},{"key":"8714_CR52","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s00259-021-05198-2","volume":"48","author":"JS Husseini","year":"2021","unstructured":"Husseini JS, Amorim BJ, Torrado-Carvajal A et al (2021) An international expert opinion statement on the utility of PET\/MR for imaging of skeletal metastases. Eur J Nucl Med Mol Imaging 48:1522\u20131537. https:\/\/doi.org\/10.1007\/s00259-021-05198-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8714_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2017.03.001","volume":"77","author":"M Kosmin","year":"2017","unstructured":"Kosmin M, Makris A, Joshi PV et al (2017) The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer. Eur J Cancer 77:109\u2013116. https:\/\/doi.org\/10.1016\/j.ejca.2017.03.001","journal-title":"Eur J Cancer"},{"key":"8714_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10549-019-05311-y","volume":"177","author":"C Oliai","year":"2019","unstructured":"Oliai C, Douek ML, Rhoane C et al (2019) Clinical features of pseudocirrhosis in metastatic breast cancer. Breast Cancer Res Treat 177:409\u2013417. https:\/\/doi.org\/10.1007\/s10549-019-05311-y","journal-title":"Breast Cancer Res Treat"},{"key":"8714_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/j.sult.2012.11.006","volume":"34","author":"B Sharma","year":"2013","unstructured":"Sharma B, Martin A, Zerizer I (2013) Positron emission tomography-computed tomography in liver imaging. Seminars in Ultrasound, CT and MRI 34:66\u201380. https:\/\/doi.org\/10.1053\/j.sult.2012.11.006","journal-title":"Seminars in Ultrasound, CT and MRI"},{"key":"8714_CR56","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2967\/jnumed.115.161455","volume":"56","author":"MP Hogan","year":"2015","unstructured":"Hogan MP, Goldman DA, Dashevsky B et al (2015) Comparison of 18F-FDG PET\/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma. J Nucl Med 56:1674\u20131680. https:\/\/doi.org\/10.2967\/jnumed.115.161455","journal-title":"J Nucl Med"},{"key":"8714_CR57","doi-asserted-by":"publisher","first-page":"20200562","DOI":"10.1259\/bjr.20200562","volume":"93","author":"N Tunariu","year":"2020","unstructured":"Tunariu N, Blackledge M, Messiou C et al (2020) What\u2019s new for clinical whole-body MRI (WB-MRI) in the 21st century. Br J Radiol 93:20200562. https:\/\/doi.org\/10.1259\/bjr.20200562","journal-title":"Br J Radiol"},{"key":"8714_CR58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/(sici)1097-0215(19970904)72:5<720::aid-ijc3>3.0.co;2-u","volume":"72","author":"P Bonnier","year":"1997","unstructured":"Bonnier P, Romain S, Dilhuydy JM et al (1997) Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72:720\u2013727. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970904)72:5<720::aid-ijc3>3.0.co;2-u","journal-title":"Int J Cancer"},{"key":"8714_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.breast.2014.01.012","volume":"23","author":"E Montagna","year":"2014","unstructured":"Montagna E, Peccatori F, Petralia G et al (2014) Whole-body magnetic resonance imaging, metastatic breast cancer and pregnancy: a case report. Breast 23:295\u2013296. https:\/\/doi.org\/10.1016\/j.breast.2014.01.012","journal-title":"Breast"},{"key":"8714_CR60","doi-asserted-by":"publisher","unstructured":"Peccatori FA, Codacci-Pisanelli G, Del Grande M et al (2017) Whole body MRI for systemic staging of breast cancer in pregnant women. Breast 35:177\u2013181. https:\/\/doi.org\/10.1016\/j.breast.2017.07.014","DOI":"10.1016\/j.breast.2017.07.014"},{"key":"8714_CR61","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00330-017-5126-z","volume":"28","author":"SN Han","year":"2018","unstructured":"Han SN, Amant F, Michielsen K et al (2018) Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study. Eur Radiol 28:1862\u20131874. https:\/\/doi.org\/10.1007\/s00330-017-5126-z","journal-title":"Eur Radiol"},{"key":"8714_CR62","unstructured":"Medicines and Healthcare Products Regulatory Agency (2021) Safety guidelines for magnetic resonance imaging equipment in clinical use. Accessed 8 Jul 2021"},{"key":"8714_CR63","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jama.2016.12126","volume":"316","author":"JG Ray","year":"2016","unstructured":"Ray JG, Vermeulen MJ, Bharatha A et al (2016) Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA 316:952\u2013961. https:\/\/doi.org\/10.1001\/jama.2016.12126","journal-title":"JAMA"},{"key":"8714_CR64","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1754-9485.2011.02263.x","volume":"55","author":"M Regier","year":"2011","unstructured":"Regier M, Schwarz D, Henes FO et al (2011) Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol 55:266\u2013274. https:\/\/doi.org\/10.1111\/j.1754-9485.2011.02263.x","journal-title":"J Med Imaging Radiat Oncol"},{"key":"8714_CR65","doi-asserted-by":"publisher","unstructured":"Paruthikunnan SM, Kadavigere R, Karegowda LH (2017) Accuracy of whole-body dwi for metastases screening in a diverse group of malignancies: comparison with conventional cross-sectional imaging and nuclear scintigraphy. AJR Am J Roentgenol 209:477\u2013490. https:\/\/doi.org\/10.2214\/AJR.17.17829","DOI":"10.2214\/AJR.17.17829"},{"key":"8714_CR66","doi-asserted-by":"crossref","unstructured":"Antoch G, Vogt FM, Freudenberg LS, Goehde SC (2016) Whole-body dual-modality PET\/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199\u20133206","DOI":"10.1001\/jama.290.24.3199"},{"key":"8714_CR67","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2214\/AJR.11.7866","volume":"199","author":"D-M Koh","year":"2012","unstructured":"Koh D-M, Blackledge M, Padhani AR et al (2012) Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 199:252\u2013262. https:\/\/doi.org\/10.2214\/AJR.11.7866","journal-title":"AJR Am J Roentgenol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08714-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-08714-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08714-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T07:21:51Z","timestamp":1660634511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-08714-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["8714"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-08714-6","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Dr. Basrull Bhaludin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because this is a retrospective review article with anonymised images and information.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because this is a retrospective review article with anonymised images and information.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 pictorial review","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}